Connect with us


US experts recommend resumption of J&J vaccine



EXPERT panel of United State, has recommended health authorities to resume Johnson & Johnson Covid-19 vaccinations, after a pause prompted by blood clot concerns.

   Health authorities proposed a halt on the vaccine following instances of severe blood clots out of millions of Americans who received the vaccine.

The panel 10 to 4 in favour of recommending the lifting of the pause, while the head of the Centers for Disease Control and Prevention (CDC) Rochelle Walensky would make the final decision.

“The Janssen Covid-19 vaccine recommended for persons 18 years of age and older in the US population under the FDA, emergency use authorization,” the experts convened by the CDC stated.

According to data presented recently, of 3.9 million women who got the Johnson & Johnson shot, 15 developed serious blood clots and three died.

The majority of the confirmed cases, 13 of the 15, was less than 50 years old. There were no reported cases among men.

Europe’s medicines regulator said that blood clots should be listed as a “very rare” side effect of Johnson & Johnson’s coronavirus vaccine.

The regulator noted its safety committee “concluded that a warning about unusual blood clots with low blood platelets should be added to the product information” for the J&J shot.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.